{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:25:43Z","timestamp":1769732743550,"version":"3.49.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ogc.2020.12.001","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T10:07:56Z","timestamp":1612865276000},"page":"53-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of Viral Complications of Pregnancy"],"prefix":"10.1016","volume":"48","author":[{"given":"Sarah C.","family":"Rogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Beigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2020.12.001_bib1","series-title":"Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14\u201349: United States, 2015\u20132016. NCHS data brief, no 304","author":"McQuillan","year":"2018"},{"issue":"8","key":"10.1016\/j.ogc.2020.12.001_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199708213370801","article-title":"The acquisition of herpes simplex virus during pregnancy","volume":"337","author":"Brown","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ogc.2020.12.001_bib3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.2010.1206","article-title":"Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects","volume":"304","author":"Pasternak","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/bdra.20013","article-title":"Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the International Acyclovir Pregnancy Registry, 1984-1999","volume":"70","author":"Stone","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"RR-03","key":"10.1016\/j.ogc.2020.12.001_bib5","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib6","first-page":"1489","article-title":"ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy","volume":"109","year":"2007","journal-title":"Obstet Gyecol"},{"issue":"18","key":"10.1016\/j.ogc.2020.12.001_bib7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM199105023241804","article-title":"Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor","volume":"324","author":"Brown","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib8","first-page":"1396","article-title":"Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review","volume":"102","author":"Sheffield","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib9","article-title":"Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection","author":"Hollier","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mob.2003.185","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery","volume":"188","author":"Watts","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2011.12.053","article-title":"Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series","volume":"161","author":"Pinninti","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","article-title":"Cytomegalovirus infection during pregnancy: state of the science","volume":"223","author":"Leruez-Ville","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"issue":"11","key":"10.1016\/j.ogc.2020.12.001_bib14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.659","article-title":"Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV","volume":"20","author":"Hyde","year":"2010","journal-title":"Rev Med Virol"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population","volume":"49","author":"Mussi-Pinhata","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib19","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ogc.2020.12.001_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A\u00a0series of 238 cytomegalovirus primary infections during pregnancy: description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J\u00a0Clin Virol"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib22","doi-asserted-by":"crossref","first-page":"380.e1-7","DOI":"10.1016\/j.ajog.2007.09.052","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pd.4340","article-title":"Detailed in utero ultrasound description of 30 cases of congenital cytomegalovirus infection","volume":"34","author":"Picone","year":"2014","journal-title":"Prenat Diagn"},{"issue":"20","key":"10.1016\/j.ogc.2020.12.001_bib24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM198511143132006","article-title":"Herpesvirus infections of pregnancy","volume":"313","author":"Stagno","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ogc.2020.12.001_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2007.09.004","article-title":"Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment","volume":"41","author":"Grosse","year":"2008","journal-title":"J\u00a0Clin Virol"},{"issue":"13","key":"10.1016\/j.ogc.2020.12.001_bib27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.19164","article-title":"Prevention of maternal-fetal transmission of CMV by hyperimmunoglobulin (HIG) administered after a primary maternal CMV infection in early gestation","volume":"53","author":"Kagan","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cid\/cis423","article-title":"Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age","volume":"55","author":"Visentin","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/infdis\/jir718","article-title":"Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children","volume":"205","author":"Nigro","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"14","key":"10.1016\/j.ogc.2020.12.001_bib31","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A\u00a0randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib32","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ajog.2019.10.082","article-title":"Randomized trial to prevent congenital cytomegalovirus","volume":"221","author":"Hughes","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib33","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajog.2019.11.018","article-title":"The effect of treatment of maternal CMV infection on the development of placental syndrome","volume":"222","author":"Saade","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ogc.2020.12.001_bib34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-0528.2007.01308.x","article-title":"Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection","volume":"114","author":"Jacquemard","year":"2007","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib35","doi-asserted-by":"crossref","first-page":"462.e1-e10","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"10253","key":"10.1016\/j.ogc.2020.12.001_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib37","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/01.AOG.0000466430.19823.53","article-title":"ACOG Practice Bulletin No. 151: cytomegalovirus, parvovirus B12, varicella zoster, and toxoplasmosis in pregnancy","volume":"125","author":"American College of Obstetricians and Gynecologists","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib38","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib39","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ogc.2020.12.001_bib40","series-title":"Global hepatitis report 2017","author":"World Health Organization","year":"2017"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajog.2015.09.100","article-title":"#38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission","volume":"214","author":"Dionne-Odom","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/01.AOG.0000263930.28382.2a","article-title":"ACOG Practice Bulletin no. 86: viral hepatitis in pregnancy","volume":"110","author":"American College of Obstetricians and Gynecologists","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"RR-16","key":"10.1016\/j.ogc.2020.12.001_bib44","first-page":"1","article-title":"A\u00a0comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib45","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/infdis\/170.6.1418","article-title":"Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load","volume":"170","author":"Burk","year":"1994","journal-title":"J\u00a0Infect Dis"},{"issue":"15","key":"10.1016\/j.ogc.2020.12.001_bib46","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0264-410X(97)00080-7","article-title":"Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity","volume":"15","author":"del Canho","year":"1997","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.ogc.2020.12.001_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: an Australian experience","volume":"190","author":"Wiseman","year":"2009","journal-title":"Med J Aust"},{"issue":"9","key":"10.1016\/j.ogc.2020.12.001_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/INF.0000000000000315","article-title":"Immunoprophylaxis failure against vertical transmission of hepatitis B virus in the Chinese population","volume":"33","author":"Lin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.ogc.2020.12.001_bib49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/M13-2529","article-title":"Prevention of vertical transmission of hepatitis B","volume":"160","author":"Kubo","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib50","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2011.10.041","article-title":"An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus","volume":"10","author":"Pan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib51","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.28302","article-title":"Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis","volume":"63","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ogc.2020.12.001_bib53","series-title":"Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 January 2020","year":"2020"},{"key":"10.1016\/j.ogc.2020.12.001_bib54","article-title":"Reproductive health and liver disease: practice guidance by the American Association for the Study of Liver Diseases","author":"Sarkar","year":"2020","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.ogc.2020.12.001_bib55","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ogc.2020.12.001_bib56","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1708131","article-title":"Tenofovir versus placebo to prevent perinatal transmission of hepatitis B","volume":"378","author":"Jourdain","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ogc.2020.12.001_bib57","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMc1805396","article-title":"Tenofovir to prevent perinatal transmission of hepatitis B","volume":"378","author":"Terrault","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ogc.2020.12.001_bib58","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJMe1801662","article-title":"A\u00a0shift in thinking to reduce mother-to-infant transmission of hepatitis B","volume":"378","author":"Dusheiko","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12962-018-0088-9","article-title":"Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea","volume":"16","author":"Lee","year":"2018","journal-title":"Cost Eff Resour Alloc"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib60","doi-asserted-by":"crossref","first-page":"231.e1-7","DOI":"10.1016\/j.ajog.2012.06.001","article-title":"Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis","volume":"207","author":"Nayeri","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.ogc.2020.12.001_bib64","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for hepatitis C virus infection in adolescents and adults: US preventive services task force recommendation statement","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib65","doi-asserted-by":"crossref","first-page":"38.e1-9","DOI":"10.1016\/j.ajog.2008.03.052","article-title":"Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington State Birth Cohort","volume":"199","author":"Pergam","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2020.12.001_bib66","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1111\/j.1365-2893.2011.01436.x","article-title":"Pregnancy outcomes associated with viral hepatitis","volume":"18","author":"Reddick","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"issue":"35","key":"10.1016\/j.ogc.2020.12.001_bib67","doi-asserted-by":"crossref","first-page":"e4777","DOI":"10.1097\/MD.0000000000004777","article-title":"Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.ogc.2020.12.001_bib68","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1478-3231.2011.02556.x","article-title":"Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes","volume":"31","author":"Connell","year":"2011","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinre.2016.07.004","article-title":"Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis","volume":"41","author":"Wijarnpreecha","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib70","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510310328","article-title":"Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women","volume":"31","author":"Conte","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib71","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7156","key":"10.1016\/j.ogc.2020.12.001_bib72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/bmj.317.7156.437","article-title":"Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection","volume":"317","author":"Resti","year":"1998","journal-title":"BMJ"},{"issue":"8945","key":"10.1016\/j.ogc.2020.12.001_bib73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(95)90277-5","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"345","author":"Zanetti","year":"1995","journal-title":"Lancet"},{"issue":"9233","key":"10.1016\/j.ogc.2020.12.001_bib74","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(00)02681-7","article-title":"Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission","volume":"356","author":"Gibb","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/jhep.2001.25885","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"34","author":"Yeung","year":"2001","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib76","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2020.12.001_bib77","author":"AASLD-IDSA"},{"key":"10.1016\/j.ogc.2020.12.001_bib78","unstructured":"World Health Organization. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection. Geneva (Switzerland); 2018. Available at: http:\/\/www.who.int\/hepatitis\/publications\/hepatitis-c-guidelines-2018\/en\/. Accessed October 19, 2020."},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib79","first-page":"154","article-title":"Direct-acting antiviral medications for chronic hepatitis C virus infection","volume":"7","author":"Jazwinski","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib80","first-page":"e221","article-title":"THU-137-DAA therapy in women of child bearing age: accidental conception during therapy and pregnancy outcome","volume":"70","author":"El-Sayed","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib81","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11904-018-0386-z","article-title":"Treatment of hepatitis C during pregnancy-weighing the risks and benefits in contrast to HIV","volume":"15","author":"Barritt","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.ogc.2020.12.001_bib83","unstructured":"Centers for Disease Control and Prevention. HIV surveillance report, 2018 (Updated); vol. 31. Available at: http:\/\/www.cdc.gov\/hiv\/libraryreports\/hiv-surveillance.html. Accessed October 21, 2020."},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib84","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/0033354918800466","article-title":"Reconsidering the number of women with HIV infection who give birth annually in the United States","volume":"133","author":"Nesheim","year":"2018","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib86","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/ciw791","article-title":"UK mother-to-child HIV transmission rates continue to decline: 2012-2014","volume":"64","author":"Peters","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ogc.2020.12.001_bib87","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib88","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib89","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM199908053410601","article-title":"Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine","volume":"341","author":"Mofenson","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ogc.2020.12.001_bib90","doi-asserted-by":"crossref","first-page":"civ578","DOI":"10.1093\/cid\/civ578","article-title":"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception","volume":"61","author":"Mandelbrot","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/QAI.0b013e3181cf9979","article-title":"Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa","volume":"54","author":"Hoffman","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.ogc.2020.12.001_bib92","article-title":"Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection","author":"Siegfried","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"10.1016\/j.ogc.2020.12.001_bib93","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib94","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/650005","article-title":"Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies\/mL at delivery: a case-control study nested in the French Perinatal Cohort (EPF-ANRS CO1)","volume":"50","author":"Tubiana","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/317918","article-title":"Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections","volume":"183","author":"John","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib96","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QAD.0b013e32801424bd","article-title":"Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding","volume":"21","author":"Graham","year":"2007","journal-title":"AIDS"},{"issue":"15","key":"10.1016\/j.ogc.2020.12.001_bib97","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00002030-200310170-00004","article-title":"Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies","volume":"17","author":"Fiore","year":"2003","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.ogc.2020.12.001_bib98","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/infdis\/jix550","article-title":"Prevalence, magnitude, and correlates of HIV-1 genital shedding in women on antiretroviral therapy","volume":"216","author":"King","year":"2017","journal-title":"J\u00a0Infect Dis"},{"issue":"16","key":"10.1016\/j.ogc.2020.12.001_bib99","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/QAD.0b013e32833e5043","article-title":"Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load","volume":"24","author":"Cu-Uvin","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3851\/IMP1856","article-title":"Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study","volume":"16","author":"Launay","year":"2011","journal-title":"Antivir Ther"},{"issue":"11","key":"10.1016\/j.ogc.2020.12.001_bib101","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40262-014-0185-7","article-title":"Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals","volume":"53","author":"McCormack","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib103","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cid\/cit374","article-title":"Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?","volume":"57","author":"Briand","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ogc.2020.12.001_bib104","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana","volume":"381","author":"Zash","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2020.12.001_bib105","unstructured":"Pereira G, Kim A, Jalil E, et\u00a0al. No occurrences of neural tube defects among 382 women on dolutegravir at pregnancy conception in Brazil. Presented at: International AIDS Society Conference. July 21-24, 2019 Mexico City, Mexico."},{"key":"10.1016\/j.ogc.2020.12.001_bib106","article-title":"Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy","author":"Sibiude","year":"2020","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib107","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2352-3018(19)30340-6","article-title":"Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study","volume":"7","author":"Williams","year":"2020","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib108","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamapediatrics.2014.1889","article-title":"Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants","volume":"169","author":"Williams","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib109","doi-asserted-by":"crossref","first-page":"e1001635","DOI":"10.1371\/journal.pmed.1001635","article-title":"Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French Perinatal Cohort Study (ANRS CO1\/CO11)","volume":"11","author":"Sibiude","year":"2014","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cid\/civ260","article-title":"In utero exposure to zidovudine and heart anomalies in the ANRS French Perinatal Cohort and the nested PRIMEVA randomized trial","volume":"61","author":"Sibiude","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ogc.2020.12.001_bib111","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/QAD.0000000000001549","article-title":"Zidovudine use in pregnancy and congenital malformations","volume":"31","author":"Rough","year":"2017","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.ogc.2020.12.001_bib112","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-0528.2010.02689.x","article-title":"Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe","volume":"117","author":"Townsend","year":"2010","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib113","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib114","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/QAI.0000000000001253","article-title":"PMTCT option B+ does not increase preterm birth risk and may prevent extreme prematurity: a retrospective cohort study in Malawi","volume":"74","author":"Chagomerana","year":"2017","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.ogc.2020.12.001_bib115","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1542\/peds.2006-1123","article-title":"Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989-2004","volume":"119","author":"Schulte","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib116","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12978-016-0149-5","article-title":"Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis","volume":"13","author":"Mesfin","year":"2016","journal-title":"Reprod Health"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0000000000001694","article-title":"Protease inhibitors and preterm delivery: another piece in the puzzle","volume":"32","author":"Favarato","year":"2018","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.ogc.2020.12.001_bib118","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/QAD.0b013e32830b8ab9","article-title":"Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, C\u00f4te d\u2019Ivoire","volume":"22","author":"Ekouevi","year":"2008","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib119","doi-asserted-by":"crossref","first-page":"e0150565","DOI":"10.1371\/journal.pone.0150565","article-title":"Preterm birth and low birth weight after in utero exposure to antiretrovirals initiated during pregnancy in Yaound\u00e9, Cameroon","volume":"11","author":"Njom Nlend","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ogc.2020.12.001_bib120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ijgo.12532","article-title":"Risk factors associated with preterm delivery and low delivery weight among HIV-exposed neonates in China","volume":"142","author":"Wang","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"10.1016\/j.ogc.2020.12.001_bib121","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/503045","article-title":"Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?","volume":"193","author":"Cotter","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.ogc.2020.12.001_bib122","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/QAD.0b013e32832be0df","article-title":"No relation between in-utero exposure to HAART and intrauterine growth retardation","volume":"23","author":"Briand","year":"2009","journal-title":"AIDS"},{"issue":"24","key":"10.1016\/j.ogc.2020.12.001_bib123","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ogc.2020.12.001_bib124","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/01.aids.0000253362.01696.9d","article-title":"Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth","volume":"20","author":"Szyld","year":"2006","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib125","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"issue":"12","key":"10.1016\/j.ogc.2020.12.001_bib126","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1086\/420834","article-title":"Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis","volume":"189","author":"Read","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.ogc.2020.12.001_bib127","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/cix1102","article-title":"Contribution of maternal antiretroviral therapy and breastfeeding to 24-month survival in human immunodeficiency virus-exposed uninfected children: an individual pooled analysis of African and Asian studies","volume":"66","author":"Arikawa","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/374273","article-title":"Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease","volume":"187","author":"Rousseau","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"24","key":"10.1016\/j.ogc.2020.12.001_bib129","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana","volume":"362","author":"Shapiro","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/INF.0b013e3181950c56","article-title":"Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-Saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding","volume":"28","author":"Marazzi","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ogc.2020.12.001_bib131","series-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2016"},{"issue":"5","key":"10.1016\/j.ogc.2020.12.001_bib132","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"10.1016\/j.ogc.2020.12.001_bib133","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib134","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajog.2010.12.033","article-title":"2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature","volume":"205","author":"Mosby","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"38","key":"10.1016\/j.ogc.2020.12.001_bib135","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.15585\/mmwr.mm6938e1","article-title":"Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19\u2013COVID-NET, 13 states, March 1-August 22, 2020","volume":"69","author":"Delahoy","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"38","key":"10.1016\/j.ogc.2020.12.001_bib136","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.15585\/mmwr.mm6938e2","article-title":"SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics\u2014eight U.S. Health Care Centers, March 1\u2013May 30, 2020","volume":"69","author":"Panagiotakopoulos","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"10.1016\/j.ogc.2020.12.001_bib137","doi-asserted-by":"crossref","first-page":"769","DOI":"10.15585\/mmwr.mm6925a1","article-title":"Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22\u2013June 7, 2020","volume":"69","author":"Ellington","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ogc.2020.12.001_bib138","doi-asserted-by":"crossref","first-page":"m2107","DOI":"10.1136\/bmj.m2107","article-title":"Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study","volume":"369","author":"Knight","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib139","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajog.2020.04.023","article-title":"Maternal deaths with coronavirus disease 2019: a different outcome from low- to middle-resource countries?","volume":"223","author":"Amorim","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/AOG.0000000000004010","article-title":"Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection: a systematic review","volume":"136","author":"Huntley","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2020.12.001_bib141","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/AOG.0000000000004025","article-title":"Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers","volume":"136","author":"Khoury","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib142","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.22088","article-title":"Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review","volume":"56","author":"Juan","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib143","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/s41467-020-18933-4","article-title":"Analysis of SARS-CoV-2 vertical transmission during pregnancy","volume":"11","author":"Fenizia","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ogc.2020.12.001_bib144","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1038\/s41467-020-17436-6","article-title":"Transplacental transmission of SARS-CoV-2 infection","volume":"11","author":"Vivanti","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ogc.2020.12.001_bib145","article-title":"Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis","author":"Kotlyar","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2020.12.001_bib146","article-title":"Detection of SARS-CoV-2 in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study","author":"Schwartz","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2020.12.001_bib147","first-page":"e204298","article-title":"Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in New York City","author":"Dumitriu","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ogc.2020.12.001_bib148","doi-asserted-by":"crossref","first-page":"151286","DOI":"10.1016\/j.semperi.2020.151286","article-title":"A\u00a0review of newborn outcomes during the COVID-19 pandemic","author":"Kyle","year":"2020","journal-title":"Semin Perinatol"},{"issue":"11","key":"10.1016\/j.ogc.2020.12.001_bib149","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.ajem.2020.08.091","article-title":"SARS-CoV-2 pharmacologic therapies and their safety\/effectiveness according to level of evidence","volume":"38","author":"Baroutjian","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ogc.2020.12.001_bib150","article-title":"OUP accepted manuscript","author":"RM","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ogc.2020.12.001_bib151","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1097\/AOG.0000000000002662","article-title":"ACOG Committee Opinion No. 741","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2020.12.001_bib152","author":"Kroger"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452030111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452030111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:51:52Z","timestamp":1768776712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985452030111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S088985452030111X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2020.12.001","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Viral Complications of Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}